David Sainati

📢 New Resource Available! We’re excited to announce the release of our most comprehensive regulation mapping of the French health data warehouse framework (Entrepôt de Données de Santé - EDS), now live in the resource section of our website. This mapping provides a detailed overview of the regulatory landscape, offering clear steps for compliance with CNIL - Commission Nationale de l'Informatique et des Libertés requirements. 🔍 What’s Inside? Our regulation mapping breaks down the EDS framework, its purpose, and who it applies to, along with the necessary actions—whether you’re a public entity or a private company needing CNIL approval. 💡 What You'll Gain This resource will help users navigate EDS framework, ensure legal compliance, and securely manage health data for research in France. A must-have guide for anyone involved in health data projects! https://lnkd.in/d7X8eQUn

8

Looking forward to sharing my perspectives and hearing how others are approaching the global VC landscape at this session at #GRIC2024!

19

🧑‍⚕️ 'Our home #nurses exchange information about #patients and make mutual decisions via Doctolib Siilo. It is crucial that they can communicate with each other securely, especially as we handle sensitive information subject to #GDPR legislation', says Julie Vanhoof, Business Unit Manager at OptiCare Thuisverpleging. Read the full interview with Julie about the use of Doctolib Siilo within their organisation (article in Dutch 🇳🇱🇧🇪) >> https://ow.ly/gwIL50RQyoJ #healthcare #ehealth #medicine #gezondheidszorg #zorg

19

3 commentaires

At Beo Healthcare, we partner with multiple health professionals to ensure that #alix, our hybrid artificial intelligence, includes the right features and benefit for patients' quality of life. Alix is designed to target multiple diseases, including #cancer We want to thank MD, brain surgeons at CHU de Brest for sharing relevant research publications with us to allow the right developments of Alix, in particular to have a solution that is customized, specific to each individual Extracts from the Abstract ⤵️: " Fatigue is one of the most common adverse effects of cancer that might persist for years after treatment completion in otherwise healthy survivors. Cancer-related fatigue causes disruption in all aspects of quality of life and might be a risk factor of reduced survival. The prevalence and course of fatigue in patients with cancer have been well characterized and there is growing understanding of the underlying biological mechanisms. Inflammation seems to have a key role in fatigue before, during, and after cancer-treatment. However, there is a considerable variability in the presentation of cancer-related fatigue, much of which is not explained by disease-related or treatment-related characteristics" "... a variety of intervention approaches have shown beneficial effects in randomized controlled trials, including physical activity, psychosocial, mind–body, and pharmacological treatments..." #md #hospital #cancer #AI #AIforHealth #Healthcare #Europe #USA #futureofmedicine #physicalactivity #customizedmedecine #patientqualityoflife #brainsurgeon #fatigue #cancerrelatedfatigue Sophie Deniel Yannick GUILLODO Chloé Le Douarin Sullivan Gauville Lucas Morisseau Maxime B'chir Benoît Quero Jean-Luc DUFOUR Mathieu Champenois Yann Le DOUARIN Nature Research Custom Media UCLA MACMILLAN PUBLISHERS INTERNATIONAL LIMITED

8

🌍 Exciting times ahead for digital health in France! I had the honor of speaking at the roundtable on "Digital Medical Devices: Where do we stand in their assessment and what healthtech stakeholders need to know?" organized by the Agence de l'innovation en santé (Lise ALTER, Camille Schurtz 👏 ) at the "Next generation of clinical research" event in Lille. The discussion was rich with insights on the current landscape of research and the future of digital therapeutics in France, especially. Special thanks to our moderator, Line FARAH (Ministère de la Santé), and my fellow speakers: Jérôme Fabiano (EIT Health France), Corinne Collignon (Haute Autorité de Santé), Sarah Zohar (INSERM), Dr. Joris Giai (CHU Grenoble Alpes) and Louisa Stüwe (Ministère de la Santé). 💡 One of the key insights: YES, foreign clinical data can be used to apply for reimbursed of a digital medical device in France! Let's connect and explore opportunities together! 🚀

95

1 commentaire

Excited to dive into the fascinating topic of Digital Twins in Healthcare with a panel of experts and Sébastien Giraudier, PhD. As the saying goes: "Put three economists in a room, and you'll get four opinions." I hope we can bring clarity and converge on a singular understanding of what a Digital Twin truly is—not just through its various use cases, but by focusing on its core digital essence. Looking forward to the discussion and the insights to come and to possibly meet you there. Book your agenda :)

4

how brillant! At #OrphanHealthcare, we've just kicked open the doors to an new opportunity that's as big as the free pizza at a startup launch! We’re getting a new office at the end of summer and offering a great, still free 120 sqm of ultra-modern office space for your, absolutely amazing! And trust me, this isn't your average, everyday office space at the edge of Zurich. It combines work and work-life balance. 😍 Here’s the Scoop on the Space: 🖐🏻 If size Matters: A whopping 350 sqm of chic, open-plan office space begging you to throw some desks and dreams into it. And 120 sqm are still available for you. 🛀🏻 Design & Comfort: It’s got everything – 2 snazzy meeting rooms for when you need to impress, a lounge for lounging (obviously), an open kitchen to test your cooking show fantasies, and even an event spot for your TEDx rehearsal. 🤓 Tech Ready: All the state-of-the-art fixings to make sure you can tweet faster, work smarter, and Netflix chill harder. ⛳ Location, Location, Location: Right on the nerve center of everything cool - next to trams, trains, and an expressway to pretty much everywhere. 🚀 Why You’ll Love It: Price Tag. It’s about amazing for the prices others pay in downtown Zurich. Flex Appeal. Mold it, shape it, and dance in it – make this space your own! Network Nirvana. Join a community of thinkers, leaders, and occasional coffee-sharing who are all on the path to greatness. 👥 Limited Edition! This isn’t a drill people, spaces like this don’t come by often and they don’t stay free for long. It’s time to level up your workplace vibe and get your team into something stellar. And 2 wonderful partners are on board: Q4BS GmbH and The Social Mall - Center for Social Quality Impact 📞 Ready to claim your space in our new corporate paradise? Hit us up at [email protected] and let’s chat about making magic happen in our new office! #Sustainable #Campus! 🎈 #OfficeSpace #Workspace #ModernOffice #BusinessOpportunity #OfficeForRent #ProfessionalSpace #CollaborationSpace

3

2 commentaires

Thank you again #Nobel Prize Laureate Jean Tirole & Pierre Dubois for a thought-provoking Health Economics Conference at Toulouse School of Economics last month! ❣ Happy to share that the replay 📹 of our panel on the use of Health Data, Platforms & Digital Technologies for Innovation is now available 👇 The panel was chaired by Jean Tirole, with Edwin Morley-Fletcher & Ariel Dora Stern 👉 I was happy to present Dassault Systèmes' ambition in #LifeSciences & #Healthcare, and how #VirtualTwin can accelerate therapeutic innovation and improve medical practice. Among examples shared, I mentioned #SCA (synthetic control arms), #MediTwin, our partnership with FDA for in silico clinical trials. Edwin Morley-Fletcher shared the ambition of European Commission to build a common platform for Human Virtual Twins and the role played by #EDITH consortium to create standards. Ariel Dora Stern shared meaningful examples of the use of #AI and #GenAI in drug discovery as well as medical practice. The ⁉ Q&A ⁉ session was quite stimulating, thank you 🙏 to the passionate attendees in the audience! 🌩 Key challenges ahead of us include: 1️⃣ Access to data, which itself requires a solid business model, data standardization, trusted Cloud 2️⃣ Reimbursement & adoption in physicians workflow -> change management will be key

27

'Healthcare platform Doctolib has conquered France — but can it take on Europe?' Lloyd Price, HealthTech M&A Advisor and Partner at Nelson Advisors shares his thoughts with Daphné Leprince-Ringuet from Sifted discussing Doctolib, their continued success, big future and potential next moves. 'Few startups in France can claim to have changed the way people behave in as systemic a way as Doctolib. Launched in 2013 by Stanislas Niox-Chateau, Doctolib has become a key component of the country’s healthcare system. Its first product — an online booking platform that lets patients schedule doctor appointments — saw huge adoption in a sector with very little digitisation. > Today, the company covers “almost all of the French population”, says Doctolib’s CFO Pierre Vergnes. It counts 80m patient accounts spanning three countries, of which the vast majority remains in France. Doctolib also has 19m users in Germany, which it expanded to in 2016, and a “nascent” number of users in Italy, launched in 2021. > During the Covid pandemic, the French government selected the company as an official partner to manage vaccination appointments. “[In France], they’re a utility company for running healthcare infrastructure now,” says Lloyd Price, a healthtech M&A advisor. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies > HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb > Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected] > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i https://lnkd.in/edDCqmrz

1

1 commentaire

🔍 France's Medtech sector is at a pivotal moment...In 2023, financial sponsor exits in French healthcare totaled just €141M compared to €1.3B in Germany and €8.1B in the US! Despite its rich history in medical innovation, the lack of local private equity investment is holding back promising companies. France currently accounts for 14% of the European medical device market but lags behind Germany’s 27%. The good news? There’s a backlog of mature French medtech firms generating revenues of €20M to €30M that are ready to scale up, but they need more local growth capital. Upcoming deals, such as Astorg’s stake in Echosens and Theravia’s exit pipeline, highlight the potential waiting to be unlocked. With the new European Commission expected to simplify regulations, the question remains: how can we harness PE support to ensure France's medtech sector thrives? Source : ION Analytics, Med Tech Europe #Healthcare #Medtech #Privateequity #Investments #France ——— I am Alexis - French pharmacist turned entrepreneur. My company BTHT is connecting senior industry experts, ex-payors, and KOLs with consultants and investors in Life Sciences and Healthcare for expert calls and senior advisory. Join 16K+ followers by clicking my name + follow 🔔 Join 1.4K+ subs to my weekly newsletter 💌

19

𝙄’𝙢 𝙩𝙝𝙧𝙞𝙡𝙡𝙚𝙙 𝙩𝙤 𝙨𝙝𝙖𝙧𝙚 𝙩𝙝𝙖𝙩 𝙢𝙮 𝙘𝙤-𝙖𝙪𝙩𝙝𝙤𝙧 Frederic Jallat 𝙖𝙣𝙙 𝙄, 𝙝𝙖𝙫𝙚 𝙥𝙪𝙗𝙡𝙞𝙨𝙝𝙚𝙙 𝙖𝙣 𝙖𝙧𝙩𝙞𝙘𝙡𝙚 𝙞𝙣 Les Echos 𝙙𝙪𝙧𝙞𝙣𝙜 𝙨𝙪𝙢𝙢𝙚𝙧 ! The article is inspired by my professional thesis on FemTech, exploring key challenges in the field — particularly how persistent discriminations contribute to gaps in women's health data.  We discuss how mental load, insecurity and cognitive biases represent 3 major barriers to achieving health equity. You can check out the full article in comment! #FemTech #HealthEquity #WomenHealth #Femmesdesante Femmes de Santé

103

11 commentaires

🧬 Latest Deals in Healthcare & Life Sciences 💼 💼 Extens has acquired a majority stake in Medicore, marking its first investment outside France, as part of its European expansion strategy, focusing on enhancing mental health solutions and EHRs for over 25,000 healthcare professionals. 💰 Kurma Partners has successfully closed €140m in its first closing of Biofund IV, aiming to raise a total of €250m by 2025 for innovative therapeutics investments. 💰 Healius has entered into a binding agreement to sell its Lumus Imaging subsidiary to Affinity Equity Partners for an enterprise value of A$965m (US$669m), enabling Healius to focus on its pathology strategy and enhance customer service and digital technologies. 🤝 Fondo Italiano d'Investimento SGR has invested €10m to acquire a minority stake in Intrauma, a developer of advanced orthopaedic medical devices, to support its growth targets and product expansion. 🇬🇧 Huma has acquired eConsult and launched Huma Workspace, aiming to create a comprehensive digital-first healthcare platform for the NHS. 💰 Asabys Partners has successfully closed its Sabadell Asabys Health Innovation Investments II Fund at €180m, surpassing its target of €150m, to invest in biopharma, medical devices, and digital health companies. 🔬 Bruker Corporation has acquired Dynamic Biosensors, enhancing its biophysical portfolio for biomolecular interaction analysis. 💼 Miura Partners has closed its fourth flagship fund, Miura Fund IV, at its hard cap of €475m, marking a total fundraising of €800m in 2024, with significant investments in family-owned businesses across healthcare, education, and other sectors 🩺 Mölnlycke Health Care has finalized its acquisition of PGF Industry Solutions, the Austrian manufacturer of Granudacyn wound cleansing and moistening solutions. Source : Investors in Healthcare ——— I am Alexis - French pharmacist turned entrepreneur. My company BTHT connects experts with consultants and investors in Life Sciences and Healthcare for expert calls and senior advisory. For more content like this 👇 Join 15K+ followers by clicking my name + follow 🔔 Join 1.4K+ subscribers to my weekly newsletter 💌

25

2 commentaires

Dear Armin Scheuer Thank you for including me in the discussion on #digitaltransformation. I appreciate the opportunity to provide my perspective on this crucial topic. From my experience, the most critical aspect of #digitaltransformation is the widespread #adoption of #digitaltechnologies across various stakeholders. 💻 Infrustructure adoption📱. Healthcare providers 🏥 must use #HealthInformationSystems (#HIS) with international standards such as #HL7 and #FHIR. Structured data can facilitate the creation of robust datasets for future AI learning and enable interoperability among different Software-as-a-Service (#SaaS) solutions. Hardware for data storage and continuous learning of AI models with security access. 📚 Policy adoption Healthcare authorities and policymakers should be agile and foster an environment conducive to a seamless and secure digital transformation process. With the rapid integration of AI technologies like ChatGPT Google Gemini #Llama, Anthropic, it is imperative to develop transparent and evidence-based AI models. We need to evaluate and determine which AI models will be most beneficial for healthcare applications. 👨‍⚕️ Human adoption. 🤒 Patients and physicians must be aware of and well-educated in the effective use of digital tools such as computers, mobile devices, and wearable devices. Without widespread adoption and proper training among healthcare professionals and patients, the successful implementation of digital transformation initiatives will be challenging. 🔑 I believe that the best adoption with collaboration of all stakeholders will helps improve value-based healthcare to save time, lives and money.

13

1 commentaire

Digital Health in France: A Snapshot Over a year after #telemonitoring was officially integrated into France's healthcare system, the digital health market is beginning to take shape. While telemonitoring is making headway, particularly in oncology, digital therapies (#DTx) are struggling to gain a foothold. ✅ Telemonitoring Leading the Way, DTx Lagging Behind France has made notable progress in telemonitoring, with systems like Resilience Pro seeing success, especially in oncology. However, DTx is still facing significant challenges. The sluggish pace is primarily due to stringent requirements for clinical and organizational benefits, coupled with the government’s public health priorities, which tend to favour oncology and mental health (like depression and anxiety) while leaving areas like rehabilitation and chronic disease management behind. ✅ Market Trends: Where Digital Health is Gaining Ground ✔ Telemonitoring Gains Momentum in Oncology: Since June 2023, telemonitoring devices have been reimbursed under the general health coverage system, with cancer monitoring tools showing strong progress (1890 health structures have declared a remote monitoring activity so far). ✔ DTx Adoption Slow: Despite the rise of digital therapies in Europe, France lags behind countries like Germany. Hannes Klöpper has recently posted valuable insight about HelloBetter's struggle to secure reimbursement from Cnedimts. ✅ France vs. Germany France’s strict regulatory landscape contrasts sharply with Germany’s more flexible DiGA program, which allows faster reimbursement for digital health applications. Germany’s approach has fostered a broad range of innovative solutions, while France’s focus remains on specific areas like oncology. This explains why Germany is ahead in DTx adoption. ✅ Navigating the French Market: Key Insights and some advise ✔ Tackle Regulatory Hurdles Head-On: Be ready for a rigorous approval process, particularly for DTx. Early engagement with French authorities and collaboration with local players will definitely help navigate this complex landscape. I would recommend an upfront check-up of your « Market Access Readiness ». Spending that time is gaining a better view on your winning strategy and evaluating your chances more efficiently. ✔ Align with Priority Areas: Products targeting government-prioritized areas like oncology and mental health are more likely to succeed. Keep an eye on evolving health priorities to position your offerings strategically. ✔ Leverage Partnerships and Pilots: Forge alliances with influent French stakeholders and participate in pilot projects like “Article 51” to enhance market entry and boost approval chances. ✔ Plan for Financial Challenges: The path to market in France is costly and time-consuming. Explore alternative business models, such as direct-to-patient sales or partnerships with private insurers, to offset upfront costs.

2

📍 [Tibi Deep Tech Roundtable] On October 15th, the Tibi Deep Tech Workshops on Digital Health and New Space gathered key experts to explore the future of innovation in these fields. Newfund was represented by Pierre Frouin, Operating Partner, who shared valuable insights into the competitive landscape of Healthcare, a strategic sector for the VC fund for more than 10 years. 🇺🇸🧠 Pierre discussed the Go-to-Market strategies for startups, highlighting the importance of balancing U.S. expansion with European growth. He explained how this approach, especially through Heka, helps accelerate progress in the BrainTech and HealthTech sectors. The roundtable also demonstrated how digital healthcare unites a wide range of players—corporations like Pfizer (Luca Mollo) and Dassault Systèmes, public institutions like Agence de l'innovation en santé and Inserm, startups like Volta Medical, and VCs such as Jefferies, Ventech, and Sofinnova Partners—all working together to foster the rise of international leaders, following Philippe Tibi’s initiative. cc Pierre Frouin, Anne-Sophie Saint-Martin, François Veron, Constant Beroulle, Carla Paillardon #Newfund #RoadToTheUSA #Heka #BrainTech #Tibi

55

2 commentaires

"What's new in healthcare innovation globally?" I had the pleasure to share my thoughts on this topic at the annual event in Paris hosted by La Poste Santé & Autonomie, which brought together the entire French #healthcare and #healthTech ecosystem. Thank you florence dupre and Olivier Barets for the invitation, and appreciation to my fellow panelists: . François BRAUN: Former Minister of Social Affairs and Health of #France . stephane pierrefitte: Deputy General Director at the University Hospital Group (Psychiatry & Neurosciences) . Hélène GUIMIOT: Head of the Health Service in the Legal Support Department of the French data protection authority (CNIL) . Kathy Malas: Director of Research, Innovation, and Learning at CISSS Montérégie-Ouest, Quebec. Special thanks to Dominique Pon, CEO of La Poste Santé & Autonomie for the great moderation (and great event). The key points of my presentations in a nutshell: The NHS, a cornerstone of British pride, is in crisis according to Lord Darzi's 2024 report (published in Sep 24) Key findings show 33% of Britons now wait over a week for GP appointments, compared to 16% in 2021. Bupa has responded by offering a subscription model for primary care: £17/month for same-day teleconsultations or £22/month for in-person visits, raising concerns about a potential two-tier system. Following the publication of the report, UK Prime Minister Sir Keir Starmer aims to transition the NHS to a digital system. There are already promising initiatives within the NHS like the 42 Integrated Care Systems (ICS) and the GP Practice Improvement Program, which has replaced 30% of face-to-face visits with text consultations. AI could also play a crucial role, with most NHS staff supporting its use in patient care (76%) and administration (81%). Four key #AI archetypes include: 1️⃣ Non-clinical AI for consumers/patients AI-based care navigation, seen with US companies like Transcarent or UnitedHealth Group's Find Care & Costs tool. 2️⃣ Clinical AI for consumers/patients AI predictive models intercepting disease through blood analysis (e.g., Function Health, Aware) or imaging (e.g., Neko Health). 3️⃣ Clinical AI for health professionals AI Clinical Decision Support (AI-CDS), especially in radiology (75% of FDA approved AI-CDS), but also beyond with companies like Tempus AI in AI-oncology. 4️⃣ Non-clinical AI for healthcare professionals AI-enhanced administrative management (like Ambient AI, ...), likely to see the fastest adoption in the short term. Three potential winners in the AI healthcare transformation: Epic: Aiming to orchestrate AI in hospitals with its App Store Showroom. Mayo Clinic: Already using 70+ AI algorithms and developing the Mayo Clinic Platform_Connect, a data hub connecting major hospitals for AI model training. La Poste Santé & Autonomie: An innovative public player acting as a trusted intermediary between healthcare systems, industry, and regulators to implement new models of care.

147

7 commentaires

✨ New week, new AI health distinction! ✨ At Synapse Medicine, Thursdays are currently all about celebration! This week, we are immensely proud to announce our selection among the top 100 digital health companies worldwide by Newsweek and Statista for 2024. We are honored to be listed among the 9 French companies in this globally recognized ranking, alongside Cardiologs, CONCILIO, Doctolib, Lifen, MEDADOM, Nabla, Wefight, and DentalMonitoring. This ranking, internationally recognized, evaluates companies based on rigorous criteria including financial performance, the impact of products or services, and the expertise of their leaders. Each recognition is a testament to the ardor and passion we put into our work, aiming to revolutionize health through artificial intelligence, in Europe as well as in the USA. 🚀 Stay connected! Who knows what next week will bring? #Innovation #DigitalHealth #AI #Excellence #Distinction #ProudTeam #HealthTech Learn more about our ranking

2

We previously discussed #QALYs in #HealthEconomicEvaluations ? But to calculate #QALYs, you need #utilities 😀 ! These are subjective values, and estimate the perception of #QualityOfLife at a certain point in time. This video describes the main methods to derive such estimates. #TTO #VAS #SG, #EQ5D, etc... these are key words you may have herd before. Wanna understand them better? Of note : all the links we share contain a summary PDF you can download, summarizing the video, so don't hesitate ! https://lnkd.in/e-7jxrfa

61

Proud to have Julian Rozenberg from Agence de l'innovation en santé visit us ! Launched in June 2021 by the President of the Republic as part of the Health Innovation 2030 plan and led by Lise ALTER, the Health Innovation Agency (AIS) is tasked with piloting and coordinating measures to promote innovations with a positive impact on patient health in France. 🎯 12 priority tasks are structured around 5 levers: Anticipating innovations and medical needs to guide public policies. Facilitating, accelerating, and simplifying the journey of an innovation, from its conception to its availability to patients. Supporting innovative project leaders at each stage of their journey. Investing to make France the leading innovative and sovereign European nation in health. Integrating prevention as a pivot for scaling up positive health outcomes for the French population.

56

2 commentaires